Episode Details

Back to Episodes
Nvidia's Pharma Play: $50M Investment Catalyzes Recursion's AI Drug Discovery

Nvidia's Pharma Play: $50M Investment Catalyzes Recursion's AI Drug Discovery

Published 2 years, 3 months ago
Description

In this episode, we explore the pharmaceutical landscape as Nvidia makes a strategic play, investing $50 million to catalyze Recursion's AI-driven drug discovery efforts. Join us as we discuss the collaborative potential, advancements in medical research, and the impact on the future of healthcare.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us